MWEFX
Price
$45.76
Change
-$0.16 (-0.35%)
Updated
Jan 29 closing price
Net Assets
2.34B
RWICX
Price
$65.21
Change
-$0.06 (-0.09%)
Updated
Jan 29 closing price
Net Assets
128.18B
Ad is loading...

MWEFX vs RWICX

Header iconMWEFX vs RWICX Comparison
Open Charts MWEFX vs RWICXBanner chart's image
MFS Global Equity A
Price$45.76
Change-$0.16 (-0.35%)
VolumeN/A
Net Assets2.34B
American Funds Capital World Gr&Inc R3
Price$65.21
Change-$0.06 (-0.09%)
VolumeN/A
Net Assets128.18B
MWEFX vs RWICX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MWEFX vs. RWICX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MWEFX is a Buy and RWICX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 128B vs. MWEFX (2.34B). RWICX pays higher dividends than MWEFX: RWICX (1.43) vs MWEFX (0.75). MWEFX was incepted earlier than RWICX: MWEFX (31 years) vs RWICX (23 years). RWICX is a more actively managed with annual turnover of: 27.00 vs. MWEFX (8.00). RWICX has a lower initial minimum investment than MWEFX: RWICX (250) vs MWEFX (1000). RWICX annual gain was more profitable for investors over the last year : 9.10 vs. MWEFX (-1.80). RWICX return over 5 years is better than : 33.62 vs. MWEFX (0.18).
MWEFXRWICXMWEFX / RWICX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years23 years-
Gain YTD6.0733.492174%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B128B2%
Annual Yield % from dividends0.751.4352%
Returns for 1 year-1.809.10-20%
Returns for 3 years-15.1913.52-112%
Returns for 5 years0.1833.621%
Returns for 10 years37.3348.6177%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESEA31.580.66
+2.13%
Euroseas Ltd
APLS29.470.19
+0.65%
Apellis Pharmaceuticals
BAX32.780.09
+0.28%
Baxter International
PX13.66-0.03
-0.22%
P10
LSTA2.50-0.18
-6.72%
Lisata Therapeutics